{"entity":{"type":"insider","cik":"0001298711","url":"/insider/0001298711","json_url":"/insider/0001298711.json","name":"Krishnan Suma","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":246,"n_filings":43,"first":"2004-08-11","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Krishnan Suma","source":"filing","n_filings":43,"first_seen":"2004-08-11","last_seen":"2026-06-05"}],"transactions":[{"id":5898044,"accession":"0001298711-26-000006","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001298711-26-000006","line_url":"/filing/0001298711-26-000006","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":308.113009112,"price_display":"308.11","price_state":"stated","total_value":7702825.2278,"total_display":"7,702,825.23","total_whole":"7,702,825","shares_owned_after":1387038.0,"shares_owned_after_display":"1,387,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider","n_lines":11},{"id":5777009,"accession":"0001298711-26-000004","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001298711-26-000004","line_url":"/filing/0001298711-26-000004","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":263.210816304,"price_display":"263.21","price_state":"stated","total_value":6580270.4076,"total_display":"6,580,270.41","total_whole":"6,580,270","shares_owned_after":1404855.0,"shares_owned_after_display":"1,404,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":10},{"id":4914609,"accession":"0001298711-25-000013","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001298711-25-000013","line_url":"/filing/0001298711-25-000013","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":220.14665724,"price_display":"220.15","price_state":"stated","total_value":11007332.862,"total_display":"11,007,332.86","total_whole":"11,007,333","shares_owned_after":1483756.0,"shares_owned_after_display":"1,483,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider","n_lines":16},{"id":4034747,"accession":"0001298711-25-000009","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001298711-25-000009","line_url":"/filing/0001298711-25-000009","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2918.0,"shares_display":"2,918","price_per_share":150.0,"price_display":"150.00","price_state":"stated","total_value":437700.0,"total_display":"437,700.00","total_whole":"437,700","shares_owned_after":1438711.0,"shares_owned_after_display":"1,438,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-16","scope":"insider","n_lines":2},{"id":4034741,"accession":"0001298711-25-000009","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001298711-25-000009","line_url":"/filing/0001298711-25-000009","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6120.0,"shares_display":"6,120","price_per_share":150.9903649019608,"price_display":"150.99","price_state":"stated","total_value":924061.0332,"total_display":"924,061.03","total_whole":"924,061","shares_owned_after":1441040.0,"shares_owned_after_display":"1,441,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-16","scope":"insider","n_lines":4},{"id":4034732,"accession":"0001298711-25-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001298711-25-000009","line_url":"/filing/0001298711-25-000009","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26835.0,"shares_display":"26,835","price_per_share":150.29773769331098,"price_display":"150.30","price_state":"stated","total_value":4033239.791,"total_display":"4,033,239.79","total_whole":"4,033,240","shares_owned_after":1512529.0,"shares_owned_after_display":"1,512,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-16","scope":"insider","n_lines":3},{"id":4767814,"accession":"0001298711-25-000007","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001298711-25-000007","line_url":"/filing/0001298711-25-000007","is_derivative":false,"issuer_cik":"0001298711","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001298711","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13727.0,"shares_display":"13,727","price_per_share":150.27268571428573,"price_display":"150.27","price_state":"stated","total_value":2062793.1568,"total_display":"2,062,793.16","total_whole":"2,062,793","shares_owned_after":1526229.0,"shares_owned_after_display":"1,526,229","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-10","filed_date":"2025-07-11","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":"2025-07-10|4767802","ledger_fault":false,"count":{"value":246,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":238,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":246},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001711279","name":"Krystal Biotech, Inc.","url":"/issuer/0001711279","role":"Director, Officer (President, R&D), Ten percent owner","n_filings":29,"first_seen":"2017-09-25","last_seen":"2026-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001356090","name":"INTREXON CORP","url":"/issuer/0001356090","role":"Officer (SVP--Product Development)","n_filings":2,"first_seen":"2014-05-13","last_seen":"2015-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001288379","name":"NEW RIVER PHARMACEUTICALS INC","url":"/issuer/0001288379","role":"Director, Officer (Vice President, Product Dev)","n_filings":12,"first_seen":"2004-08-11","last_seen":"2006-11-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298711","retrieved_at":"2026-08-26T02:27:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}